{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:23:58Z","timestamp":1791944638302,"version":"4.3.4"},"reference-count":49,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Recent studies reveal that a growing proportion of children with hematologic malignancies (HM) harbor germ line pathogenic or likely pathogenic variants (PV) in cancer-predisposing genes (CPG). Identifying these children is critical because the information gained guides leukemia therapy, family testing, and selection of related donors for hematopoietic cell transplantation (HCT). Nevertheless, it remains unclear how often children with HM being considered for HCT undergo genetic evaluation and whether germ line data are used to guide clinical practice. To address this gap, we reviewed the records of 286 children who underwent \u22651 HCT for HM at St. Jude Children's Research Hospital between 1 January 2017 and 31 December 2023. We examined the timeline of genetic evaluation, prevalence of germ line PV, and impact of PV on HCT outcomes. Overall, 227 (79%) children met with a genetic counselor before their first HCT, 192 underwent testing, and 142 had results returned before the HCT. Thirty-six patients (19%) harbored a germ line CPG PV, among whom 12 (6%) had PV aligning with their HM diagnosis. Of 5 patients who received an HCT from a PV-positive relative, 1 patient developed donor-derived leukemia. We observed no significant differences in time to neutrophil engraftment, cumulative incidence of relapse, or overall survival between patients with and without PV, although the cohort was heterogeneous with respect to the underlying PV. Given the high prevalence of PV in children with HM, prompt referral to genetics is warranted to ensure timely counseling and germ line testing to detect a hereditary predisposition and inform donor selection for HCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026020262","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:18:14Z","timestamp":1783531094000},"page":"6489-6500","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of germ line testing for children with hematologic malignancies undergoing hematopoietic cell transplantation"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0262-5835","authenticated-orcid":false,"given":"Arti S.","family":"Pandey","sequence":"first","affiliation":[{"name":"1Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Mostafavi","sequence":"additional","affiliation":[{"name":"2Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ashcraft","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhou","family":"Wu","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Keerthi","sequence":"additional","affiliation":[{"name":"4Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Lewis","sequence":"additional","affiliation":[{"name":"5Department of Hematology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7392-6515","authenticated-orcid":false,"given":"Rose B.","family":"McGee","sequence":"additional","affiliation":[{"name":"1Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1336-7106","authenticated-orcid":false,"given":"Alise","family":"Blake","sequence":"additional","affiliation":[{"name":"1Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LilyAnne M.","family":"Grieve","sequence":"additional","affiliation":[{"name":"1Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0527-8418","authenticated-orcid":false,"given":"Stacy","family":"Hines-Dowell","sequence":"additional","affiliation":[{"name":"6Center of Advanced Practice, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Harrison","sequence":"additional","affiliation":[{"name":"1Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9806-0217","authenticated-orcid":false,"given":"Ninad","family":"Oak","sequence":"additional","affiliation":[{"name":"1Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Taylor","sequence":"additional","affiliation":[{"name":"1Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0598-7102","authenticated-orcid":false,"given":"Melissa R.","family":"Perrino","sequence":"additional","affiliation":[{"name":"1Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Suliman","sequence":"additional","affiliation":[{"name":"4Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Maciaszek","sequence":"additional","affiliation":[{"name":"7Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-0666","authenticated-orcid":false,"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"7Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-9980","authenticated-orcid":false,"given":"Brandon","family":"Triplett","sequence":"additional","affiliation":[{"name":"4Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5581-6555","authenticated-orcid":false,"given":"Kim E.","family":"Nichols","sequence":"additional","affiliation":[{"name":"1Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"24","key":"2026101310414748400_bib1","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood.2022015790","article-title":"Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages","volume":"140","author":"Feurstein","year":"2022","journal-title":"Blood"},{"issue":"22","key":"2026101310414748400_bib2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood.2021012666","article-title":"Childhood acute myeloid leukemia shows a high level of germline predisposition","volume":"138","author":"Samaraweera","year":"2021","journal-title":"Blood"},{"issue":"10","key":"2026101310414748400_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(23)00403-5","article-title":"Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study","volume":"24","author":"Chen","year":"2023","journal-title":"Lancet Oncol"},{"issue":"7","key":"2026101310414748400_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.clml.2016.04.001","article-title":"Evaluation of patients and families with concern for predispositions to hematologic malignancies within the Hereditary Hematologic Malignancy Clinic (HHMC)","volume":"16","author":"DiNardo","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"19","key":"2026101310414748400_bib5","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1182\/blood-2010-12-326322","article-title":"First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation","volume":"117","author":"Xiao","year":"2011","journal-title":"Blood"},{"issue":"18","key":"2026101310414748400_bib6","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood-2018-07-861070","article-title":"Donor-derived MDS\/AML in families with germline GATA2 mutation","volume":"132","author":"Galera","year":"2018","journal-title":"Blood"},{"issue":"4","key":"2026101310414748400_bib7","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/leu.2017.44","article-title":"Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation","volume":"31","author":"Kobayashi","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"2026101310414748400_bib8","first-page":"255","article-title":"Donor-derived malignancy and transplantation morbidity: risks of patient and donor genetics in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Williams","year":"2024","journal-title":"Transpl Cell Ther"},{"issue":"1","key":"2026101310414748400_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bjh.18675","article-title":"Germline predisposition to haematological malignancies: best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group","volume":"201","author":"Speight","year":"2023","journal-title":"Br J Haematol"},{"issue":"6","key":"2026101310414748400_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11899-022-00684-2","article-title":"Approach toward germline predisposition syndromes in patients with hematologic malignancies","volume":"17","author":"Atluri","year":"2022","journal-title":"Curr Hematol Malig Rep"},{"issue":"2","key":"2026101310414748400_bib11","doi-asserted-by":"crossref","first-page":"e1959","DOI":"10.1002\/jgc4.1959","article-title":"Risk assessment and genetic counseling for hematologic malignancies-practice resource of the National Society of Genetic Counselors","volume":"34","author":"Stewart","year":"2025","journal-title":"J Genet Couns"},{"key":"2026101310414748400_bib12","unstructured":"National Comprehensive Cancer Network\n          . NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Myelodysplastic Syndromes. 2026. Version 3. Accessed 25 July 2026. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mds.pdf)https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mds.pdf."},{"issue":"4","key":"2026101310414748400_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cll.2023.06.004","article-title":"Germline predisposition to myeloid neoplasms: diagnostic concepts and classifications","volume":"43","author":"Obiorah","year":"2023","journal-title":"Clin Lab Med"},{"issue":"1","key":"2026101310414748400_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/17474086.2020.1685866","article-title":"Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia","volume":"13","author":"Bloom","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"2026101310414748400_bib15","first-page":"1","volume-title":"WHO Classification of Tumors Editorial Board","author":"WHO Classification of Tumours","year":"2024","edition":"5th ed."},{"issue":"19","key":"2026101310414748400_bib16","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1158\/1078-0432.CCR-24-0685","article-title":"Update on recommendations for surveillance for children with predisposition to hematopoietic malignancy","volume":"30","author":"Maese","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2026101310414748400_bib17","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1158\/1078-0432.CCR-17-0428","article-title":"Recommendations for surveillance for children with leukemia-predisposing conditions","volume":"23","author":"Porter","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2026101310414748400_bib18","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41375-025-02750-z","article-title":"Insights into germline predisposition to pediatric lymphoid malignancies","volume":"39","author":"Thapa","year":"2025","journal-title":"Leukemia"},{"key":"2026101310414748400_bib19","unstructured":"R Core Team\n          . R: A Language and Environment for Statistical Computing. 2024. Accessed 14 July 2026. https:\/\/www.R-project.org\/."},{"issue":"19","key":"2026101310414748400_bib20","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1182\/bloodadvances.2023009742","article-title":"Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome","volume":"7","author":"Guijarro","year":"2023","journal-title":"Blood Adv"},{"issue":"2","key":"2026101310414748400_bib21","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.18632\/oncotarget.23328","article-title":"Fanconi anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML","volume":"9","author":"Przychodzen","year":"2018","journal-title":"Oncotarget"},{"issue":"4","key":"2026101310414748400_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.hoc.2018.04.007","article-title":"Monosomy 7 in pediatric myelodysplastic syndromes","volume":"32","author":"Wlodarski","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"2026101310414748400_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1470-2045(24)00026-3","article-title":"Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study","volume":"25","author":"Ercan","year":"2024","journal-title":"Lancet Oncol"},{"issue":"7","key":"2026101310414748400_bib24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","article-title":"Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database","volume":"67","author":"Moller","year":"2018","journal-title":"Gut"},{"issue":"1","key":"2026101310414748400_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"issue":"2","key":"2026101310414748400_bib26","doi-asserted-by":"crossref","first-page":"pkab007","DOI":"10.1093\/jncics\/pkab007","article-title":"Frequency of pathogenic germline variants in cancer-susceptibility genes in the Childhood Cancer Survivor Study","volume":"5","author":"Kim","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"2026101310414748400_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cancergen.2023.08.112","article-title":"A hematologic case with germline deletion of PMS2 and increased risk of HNPCC studied by optical genome mapping and NGS","volume":"278-279","author":"Xu","year":"2023","journal-title":"Cancer Genet"},{"issue":"11","key":"2026101310414748400_bib28","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/jnci\/djac151","article-title":"Heterozygous BRCA1 and BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer","volume":"114","author":"Kratz","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"2026101310414748400_bib29","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/bjc.2016.58","article-title":"The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study","volume":"114","author":"Iqbal","year":"2016","journal-title":"Br J Cancer"},{"issue":"11","key":"2026101310414748400_bib30","doi-asserted-by":"crossref","first-page":"e0221288","DOI":"10.1371\/journal.pone.0221288","article-title":"Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia","volume":"14","author":"Pouliot","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"2026101310414748400_bib31","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jamaoncol.2019.2203","article-title":"Association of germline BRCA2 mutations with the risk of pediatric or adolescent non-Hodgkin lymphoma","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"2026101310414748400_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3324\/haematol.2022.281580","article-title":"Germline loss-of-function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies","volume":"109","author":"Stubbins","year":"2024","journal-title":"Haematologica"},{"issue":"1","key":"2026101310414748400_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3324\/haematol.2023.283348","article-title":"BRCA1\/2 mutations and de novo hematologic malignancies: true, true and not clearly related","volume":"109","author":"Shah","year":"2024","journal-title":"Haematologica"},{"issue":"7","key":"2026101310414748400_bib34","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s41375-025-02635-1","article-title":"Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants","volume":"39","author":"Stubbins","year":"2025","journal-title":"Leukemia"},{"issue":"4","key":"2026101310414748400_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11899-022-00663-7","article-title":"Germline CHEK2 and ATM variants in myeloid and other hematopoietic malignancies","volume":"17","author":"Stubbins","year":"2022","journal-title":"Curr Hematol Malig Rep"},{"issue":"21","key":"2026101310414748400_bib36","first-page":"4830","article-title":"Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13","volume":"55","author":"Gudmundsson","year":"1995","journal-title":"Cancer Res"},{"issue":"3","key":"2026101310414748400_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11684-021-0841-x","article-title":"Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies","volume":"16","author":"Nie","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"2026101310414748400_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.gim.2021.08.013","article-title":"Risk of cancer in heterozygous relatives of patients with Fanconi anemia","volume":"24","author":"McReynolds","year":"2022","journal-title":"Genet Med"},{"issue":"7","key":"2026101310414748400_bib39","doi-asserted-by":"crossref","first-page":"994","DOI":"10.7326\/M21-4109","article-title":"The challenge of genetic variants of uncertain clinical significance: a narrative review","volume":"175","author":"Burke","year":"2022","journal-title":"Ann Intern Med"},{"issue":"5","key":"2026101310414748400_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"11","key":"2026101310414748400_bib41","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.bbmt.2019.07.007","article-title":"Outcomes of hematopoietic cell transplantation in patients with germline SAMD9\/SAMD9L mutations","volume":"25","author":"Ahmed","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"2026101310414748400_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/bloodadvances.2017012682","article-title":"Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype","volume":"2","author":"Sarthy","year":"2018","journal-title":"Blood Adv"},{"issue":"8","key":"2026101310414748400_bib43","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.bbmt.2020.04.029","article-title":"Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome","volume":"26","author":"Myers","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"issue":"13","key":"2026101310414748400_bib44","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood.2022017739","article-title":"Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances","volume":"141","author":"Reilly","year":"2023","journal-title":"Blood"},{"issue":"11","key":"2026101310414748400_bib45","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/s41409-021-01374-y","article-title":"Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome","volume":"56","author":"Bortnick","year":"2021","journal-title":"Bone Marrow Transpl"},{"issue":"11","key":"2026101310414748400_bib46","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2026101310414748400_bib47","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbmt.2020.02.015","article-title":"Comparison of outcomes of myeloablative allogeneic stem cell transplantation for pediatric patients with bone marrow failure, myelodysplastic syndrome and acute myeloid leukemia with and without germline GATA2 mutations","volume":"26","author":"Hofmann","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"2026101310414748400_bib48","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.2022016508","article-title":"Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes","volume":"140","author":"McReynolds","year":"2022","journal-title":"Blood"},{"issue":"12","key":"2026101310414748400_bib49","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/ajh.70093","article-title":"Germline pathogenic variants in MUTYH are associated with inferior survival after hematopoietic cell transplantation in patients with hematologic malignancies or disorders","volume":"100","author":"Rafati","year":"2025","journal-title":"Am J Hematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6489\/2590951\/blooda_adv-2026-020262-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6489\/2590951\/blooda_adv-2026-020262-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:42:01Z","timestamp":1791902521000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/19\/6489\/569590\/Outcomes-of-germ-line-testing-for-children-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":49,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026020262","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,13]]},"published":{"date-parts":[[2026,9,25]]}}}